Advertisement

Pharmacokinetics from a dynamical systems point of view

  • J. M. van Rossum
  • J. E. G. M. de Bie
  • G. van Lingen
  • H. W. A. Teeuwen
Perspectives in Pharmacokinetics

Keywords

Caffeine Transit Time Antipyrine Transport Function Extraction Ratio 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. Garfinkel. A mathematics for physiology.Am. J. Physiol. 245:R455-R466 (1983).PubMedGoogle Scholar
  2. 2.
    J. J. d'Azzo and C. H. Houpis.Linear Control System Analysis and Design, 3rd ed., McGraw Hill, New York, 1981.Google Scholar
  3. 3.
    J. P. Crutchfield, J. D. Farmer, N. H. Packard, and R. S. Shaw. Chaos.Sci. Am. 255:38–49 (1986).Google Scholar
  4. 4.
    R. G. Harrison and D. J. Biswas. Chaos in light. Nature321:394–401 (1986).CrossRefGoogle Scholar
  5. 5.
    E. Ott. Strange attractors and chaotic motions of dynamical systems.Rev. Mod. Phys. 53:655 (1981).CrossRefGoogle Scholar
  6. 6.
    H. G. Schuster.Deterministic Chaos. Physik Verlag Weinheim, FRG, 1984.Google Scholar
  7. 7.
    R. H. Abraham and C. D. Shaw.Dynamics. The Geometry of Behavior, Pt. 2:Chaotic Behavior, Aerial Press, Santa Cruz, Ca, 1984.Google Scholar
  8. 8.
    N. H. Packard, J. P. Crutchfield, J. D. Farmer, and R. S. Shaw. Geometry from a time series.Phys. Rev. Lett. 45:712–716 (1980).CrossRefGoogle Scholar
  9. 9.
    C. Nicolis and G. Nicolis. Is there a climatic attractor?Nature 311:529–532 (1984).CrossRefGoogle Scholar
  10. 10.
    P. Grassberger. Do climatic attractors exist?Nature 323:609–611 (1985).CrossRefGoogle Scholar
  11. 11.
    J. L. Stephenson. Theory of transport in linear biological systems.Bull. Math. Biophys. 22:131–138 (1960).Google Scholar
  12. 12.
    K. L. Zierler. Theoretical basis of indicator-dilution methods for measuring flow and volume.Circ. Res. 10:393–407 (1962).CrossRefGoogle Scholar
  13. 13.
    J. B. Bassingthwaighte. Blood flow and diffusion through mammalian organs.Science 167:1347–1353 (1970).PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    C. Waterhouse and J. Keilson. Transfer times across the human body.Bull. Math. Biophys. 34:33–44 (1972).PubMedCrossRefGoogle Scholar
  15. 15.
    R. V. Churchill.Operational Mathematics. McGraw Hill, Kogakusha, Tokyo, 1972.Google Scholar
  16. 16.
    A. Papoulis.Probability, Random Variables and Stochastic Processes, McGraw Hill, Kogakusha, Tokyo, 1965.Google Scholar
  17. 17.
    K. Yamaoka, T. Nakagawa, and T. Uno. Statistical moments in pharmacokinetics.J. Pharmacokin. Biopharm. 6:547–558 (1978).CrossRefGoogle Scholar
  18. 18.
    S. Grodins.Control Theory and Biological Systems, Columbia University Press, New York, 1963.Google Scholar
  19. 19.
    N. A. Lassen and W. Perl.Tracer Kinetic Methods in Medical Physiology, Raven Press, New York, 1979.Google Scholar
  20. 20.
    J. J. Di Stefano, A. R. Stubberub, and I. J. Williams.Feedback and Control Systems, McGraw Hill, New York, 1976.Google Scholar
  21. 21.
    H. T. Milhorn.The Application of Control Theory to Physiological Systems, W. B. Saunders, Philadelphia, 1966.Google Scholar
  22. 22.
    D. P. Vaughan and I. Hope. Applications of a recirculatory stochastic pharmacokinetic model: Limitations of compartmental models.J. Pharmacokin. Biopharm. 7:207–225 (1979).CrossRefGoogle Scholar
  23. 23.
    D. J. Cutler. A linear recirculation model for drug disposition,J. Pharmacokin. Biopharm. 7:101–116 (1979).CrossRefGoogle Scholar
  24. 24.
    J. M. van Rossum, J. Burgers, G. van Lingen, and J. de Bie. Pharmacokinetics: A dynamic systems approach.TIPS, January, 1983.Google Scholar
  25. 25.
    M. Weiss and W. Föster. Pharmacokinetic models based on circulatory transport.Eur. J. Clin. Pharmacol. 16:287–297 (1979).CrossRefGoogle Scholar
  26. 26.
    K. Yamaoka, T. Nakagawa, and H. Tanaka. Recirculatory moment analysis of drugs in man.Chem. Pharm. Bull. 33:784–794 (1985).PubMedCrossRefGoogle Scholar
  27. 27.
    M. Weiss. Modelling of initial distribution of drugs following intravenous bolus injection.Eur. J. Clin. Pharmacol. 24: 121–126 (1983).PubMedCrossRefGoogle Scholar
  28. 28.
    J. M. van Rossum, O. Steyger, T. van Uem, G. J. Binkhorst, and R. A. A. Maes. Pharmacokinetics by using mathematical systems dynamics. In J. Eisenfeld and M. Witten (eds.),Modelling of Biomedical Systems, Elsevier, Amsterdam 1986, pp. 121–126.Google Scholar
  29. 29.
    J. M. van Rossum, G. van Lingen, and R. A. A. Maes. Analysis of the pharmacokinetic body transport function.Math. Comput. Model. 11:610–614 (1988).CrossRefGoogle Scholar
  30. 30.
    H. W. A. Teeuwen, P. J. de Schepper, T. B. Tjandramaga, A. van Hecken, R. Veldhuis, and J. M. van Rossum. Intravenous single dose pharmacokinetics of caffeine.Eur. J. Clin. Pharmacol. (in press).Google Scholar
  31. 31.
    H. W. A. Teeuwen, T. B. Tjandramaga, A. van Hecken, and J. M. van Rossum. Clinical pharmacokinetics of paraxanthine.Eur. J. Clin. Pharmacol. (in press).Google Scholar
  32. 32.
    H. W. A. Teeuwen, A. van Hecken, T. B. Tjandramaga, and J. M. van Rossum. Oral and single dose kinetics of quinine.Eur. J. Clin. Pharmacol. (in press).Google Scholar
  33. 33.
    D. P. Vaughan and M. Dennis. Mathematical basis of point-area deconvolution method for determining in vivo input functions,J. Pharm. Sci. 67:663–665.Google Scholar
  34. 34.
    S. Øle, J. G. Gambertoglio, and L. Fleckenstein. Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing.J. Pharmacokin. Biopharm. 10:157–172 (1982).CrossRefGoogle Scholar
  35. 35.
    J. Raaflaub and U. C. Dubach. On the pharmacokinetics of phenacetin in man.Eur. J. Clin. Pharmacol. 8:261–265 (1975).PubMedCrossRefGoogle Scholar
  36. 36.
    M. D. Rawlins, D. B. Henderson, and A. R. Hijab. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.Eur. J. Clin. Pharmacol. 11:283–286 (1977).PubMedCrossRefGoogle Scholar
  37. 37.
    M. Eichelbaum, H. R. Ochs, G. Roberts, and A. Somogyi. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.Arzneim.-Forsch. 32:575–578 (1982).Google Scholar
  38. 38.
    U. Breyer-Pfaff, M. Harder, and E. H. Egberts. Plasma levels of parent drug and metabolites in the intravenous aminopyrine breath test.Eur. J. Clin. Pharmacol. 21:521–528 (1982).PubMedCrossRefGoogle Scholar
  39. 39.
    P. A. Mitenko and R. I. Ogilvie. Pharmacokinetics of intravenous theophylline.Clin. Pharmacol. Ther. 14:509–513 (1973).PubMedGoogle Scholar
  40. 40.
    N. L. Benowitz, P. Jacob, R. T. Jones, and J. Rosenberg. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.J. Pharmacol. Exp. Ther. 221:368 (1982).PubMedGoogle Scholar
  41. 41.
    P. J. de Schepper, A. van Hecken, P. Daenens, and J. M. van Rossum. Kinetics of cotinine after oral and intravenous administration in man (in preparation).Google Scholar
  42. 42.
    S. M. Huang, N. K. Alhanikan, K. Sridhar, Y. C. Huang, and W. L. Chiou. Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.Eur. J. Clin. Pharmacol. 22:359–365 (1982).PubMedCrossRefGoogle Scholar
  43. 43.
    R. Jochemsen, J. J. H. Hogendoorn, J. Dingemanse, J. Hermans, J. K. Boeijinga, and D. D. Breimer. Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans.J. Pharmacokin. Biopharm. 10:231–245 (1982).CrossRefGoogle Scholar
  44. 44.
    U. Klotz and G. Ziegler. Physiologic and temporal variation in hepatic elimination of midazolam.Clin. Pharmacol. Ther. 32:107–112 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • J. M. van Rossum
    • 1
    • 2
  • J. E. G. M. de Bie
    • 1
    • 2
  • G. van Lingen
    • 1
    • 2
  • H. W. A. Teeuwen
    • 1
    • 2
  1. 1.Department of PharmacologyUniversity of Nijmegen, Foundation of Dynamical Systems PharmacologyNijmegen
  2. 2.The Netherlands Institute of Drugs and Doping ResearchUniversity of UtrechtThe Netherlands

Personalised recommendations